Holen Sie sich die Stockscreener-App
6.50
4.13%
-0.28
Handel nachbörslich:
6.20
-0.30
-4.62%
Schlusskurs vom Vortag:
$6.78
Offen:
$6.9
24-Stunden-Volumen:
2.30M
Relative Volume:
1.21
Marktkapitalisierung:
$1.12B
Einnahmen:
$25.55M
Nettoeinkommen (Verlust:
$-341.97M
KGV:
-2.3214
EPS:
-2.8
Netto-Cashflow:
$-304.44M
1W Leistung:
+18.61%
1M Leistung:
+60.10%
6M Leistung:
+192.79%
1J Leistung:
-1.22%
1-Tages-Spanne:
$6.21
$7.00
1-Wochen-Bereich:
$5.47
$7.00
52-Wochen-Spanne:
$1.775
$7.07
Relay Therapeutics Inc Stock (RLAY) Company Profile
Firmenname
Relay Therapeutics Inc
Sektor
Branche
Telefon
617-370-8837
Adresse
60 HAMPSHIRE STREET, CAMBRIDGE
Vergleichen Sie RLAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
6.50 | 1.17B | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | Guggenheim | Buy |
| 2025-04-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-10 | Fortgesetzt | Goldman | Buy |
| 2024-09-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-04-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Eingeleitet | Raymond James | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-09-30 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-02 | Eingeleitet | Stifel | Buy |
| 2022-06-06 | Eingeleitet | Jefferies | Underperform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-07-21 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-10 | Eingeleitet | Cowen | Outperform |
| 2020-08-10 | Eingeleitet | Goldman | Buy |
| 2020-08-10 | Eingeleitet | Guggenheim | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
Multi asset correlation models including Relay Therapeutics Inc.Portfolio Performance Summary & Weekly Market Pulse Alerts - newser.com
Can trapped investors hope for a rebound in Relay Therapeutics Inc.July 2025 Opening Moves & Capital Protection Trade Alerts - newser.com
Can a trend reversal in Relay Therapeutics Inc. lead to recoveryMarket Risk Report & Capital Efficiency Focused Ideas - newser.com
Using Bollinger Bands to evaluate Relay Therapeutics Inc.Trade Entry Summary & Long-Term Safe Return Strategies - newser.com
Short interest data insights for Relay Therapeutics Inc.July 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com
Will Relay Therapeutics Inc. stock benefit from green energy trendsQuarterly Profit Review & Proven Capital Preservation Tips - newser.com
Is Relay Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Gains Summary & Smart Investment Allocation Tips - newser.com
Does Relay Therapeutics Inc. qualify in momentum factor screening2025 Volatility Report & Weekly High Momentum Picks - newser.com
Relay Therapeutics Inc. stock prediction for this weekM&A Rumor & Low Volatility Stock Suggestions - newser.com
Is Relay Therapeutics Inc. stock poised for growth2025 Price Momentum & Reliable Entry Point Trade Alerts - newser.com
Is Relay Therapeutics Inc. stock bottoming outWatch List & Free Verified High Yield Trade Plans - newser.com
Relay Therapeutics, Inc. $RLAY Shares Sold by Voya Investment Management LLC - Defense World
Is Relay Therapeutics Inc a good long term investmentPrice Action Analysis & Affordable Market Trading - earlytimes.in
What analysts say about Relay Therapeutics Inc stockPrice Action Analysis & Affordable Market Growth - earlytimes.in
Relay Therapeutics (NASDAQ:RLAY) Shares Up 7%Time to Buy? - MarketBeat
Institutional scanner results for Relay Therapeutics Inc.July 2025 Short Interest & Weekly High Conviction Trade Ideas - newser.com
Relay Therapeutics (NASDAQ:RLAY) Trading 7.9% HigherTime to Buy? - MarketBeat
Relative strength of Relay Therapeutics Inc. in sector analysisTrade Signal Summary & Safe Entry Zone Identification - newser.com
Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608 - Yahoo Finance
Acadian Asset Management LLC Buys 653,081 Shares of Relay Therapeutics, Inc. $RLAY - MarketBeat
Goldman Sachs Group Inc. Sells 627,974 Shares of Relay Therapeutics, Inc. $RLAY - MarketBeat
Relay Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators - Markets Mojo
Volatility Watch: Can Relay Therapeutics Inc expand its profit marginsMarket Movement Recap & Expert Verified Stock Movement Alerts - khodrobank.com
History Review: What are Relay Therapeutics Incs growth leversEarnings Miss & Low Risk Growth Stock Ideas - خودرو بانک
Bull Bear: Whats the beta of Relay Therapeutics Inc stockWeekly Investment Summary & Long-Term Safe Return Strategies - خودرو بانک
Growth Value: Should I hold or sell REGCO now2025 Market Trends & Fast Gain Swing Alerts - khodrobank.com
Analysts Set Relay Therapeutics, Inc. (NASDAQ:RLAY) Target Price at $16.50 - MarketBeat
Aug Opening: Is Unifi Inc. subject to activist investor interestVolume Spike & Advanced Swing Trade Entry Alerts - khodrobank.com
Aug Spikes: Can Relay Therapeutics Inc expand into new markets2025 Trading Volume Trends & Stepwise Trade Execution Plans - خودرو بانک
Growth Review: Will Relay Therapeutics Inc benefit from government policy2025 Short Interest & Weekly Top Performers Watchlists - خودرو بانک
Relay Therapeutics’ SWOT analysis: AI-driven biotech stock faces pivotal phase - Investing.com
Portfolio Recap: Is Relay Therapeutics Inc likely to announce a buybackMarket Trend Report & Weekly Consistent Profit Watchlists - خودرو بانک
Trading Recap: Will Translational Development Acquisition Corp. outperform during market ralliesWeekly Risk Summary & Real-Time Volume Analysis - khodrobank.com
Trend analysis for Relay Therapeutics Inc. this weekEarnings Risk Report & Technical Confirmation Alerts - newser.com
Is Relay Therapeutics Inc stock showing strong momentum2025 Growth vs Value & Weekly Breakout Watchlists - خودرو بانک
What institutional flow reveals about Relay Therapeutics Inc.July 2025 Final Week & Risk Managed Investment Signals - newser.com
Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Relay Therapeutics Inc-Aktie (RLAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Jul 28 '25 |
Sale |
3.74 |
1,359 |
5,083 |
393,722 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 29 '25 |
Sale |
3.68 |
18,380 |
67,638 |
335,295 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 28 '25 |
Sale |
3.74 |
1,701 |
6,362 |
353,675 |
| Bergstrom Donald A | President, R&D |
Jul 29 '25 |
Sale |
3.68 |
26,701 |
98,260 |
552,720 |
| Bergstrom Donald A | President, R&D |
Jul 28 '25 |
Sale |
3.74 |
4,069 |
15,218 |
579,421 |
| Adams Brian | Chief Legal Officer |
Jul 29 '25 |
Sale |
3.68 |
18,276 |
67,256 |
371,472 |
| Adams Brian | Chief Legal Officer |
Jul 28 '25 |
Sale |
3.74 |
1,637 |
6,122 |
389,748 |
| Patel Sanjiv | President and CEO |
Jul 09 '25 |
Sale |
3.57 |
61,379 |
219,123 |
765,288 |
| Rahmer Peter | See remarks |
Apr 30 '25 |
Sale |
3.00 |
10,739 |
32,217 |
390,081 |
| Rahmer Peter | See remarks |
Apr 28 '25 |
Sale |
3.17 |
1,364 |
4,324 |
400,820 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):